{"id":25745,"date":"2025-05-23T11:55:54","date_gmt":"2025-05-23T15:55:54","guid":{"rendered":"https:\/\/aafa.org\/?p=25745"},"modified":"2025-05-23T18:57:38","modified_gmt":"2025-05-23T22:57:38","slug":"chronic-disease-prevalence-in-the-united-states","status":"publish","type":"post","link":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/","title":{"rendered":"Chronic Disease Prevalence in the United States"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;News T-Hero Section&#8221; module_class=&#8221;hero tert&#8221; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_News.jpg&#8221; background_position=&#8221;top_right&#8221; custom_padding=&#8221;1%||1%||true|false&#8221; global_module=&#8221;2297&#8243; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;bottom_left&#8221; background_horizontal_offset=&#8221;0%&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;2%||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Nav Parent Title&#8221; module_class=&#8221;tert-parent&#8221; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; header_2_font_size=&#8221;32px&#8221; custom_margin=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>News<\/h2>\n<p>[\/et_pb_text][et_pb_code admin_label=&#8221;Breadcrumbs&#8221; module_class=&#8221;bcrumb&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; text_orientation=&#8221;left&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;font-size:16px;||color: #fff;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Main Content&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;bottom_right&#8221; custom_padding=&#8221;2%||2%||true|false&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;Title Row&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_post_title author=&#8221;off&#8221; comments=&#8221;off&#8221; featured_image=&#8221;off&#8221; admin_label=&#8221;Blog Post Title&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h2&#8243; title_font=&#8221;|600|||||||&#8221; title_text_color=&#8221;#008C99&#8243; title_font_size=&#8221;39px&#8221; meta_font=&#8221;|700|||||||&#8221; meta_text_color=&#8221;#505050&#8243; meta_font_size=&#8221;20px&#8221; title_font_size_tablet=&#8221;30px&#8221; title_font_size_phone=&#8221;26px&#8221; title_font_size_last_edited=&#8221;on|phone&#8221; meta_font_size_tablet=&#8221;20px&#8221; meta_font_size_phone=&#8221;16px&#8221; meta_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=&#8221;Content Row&#8221; module_class=&#8221;blog-single&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Page Content&#8221; module_class=&#8221;secondary-intro&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; text_line_height=&#8221;1.5em&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_text_color=&#8221;#008c99&#8243; header_2_font_size=&#8221;39px&#8221; custom_margin=&#8221;||3%||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><em>Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases<\/em><\/p>\n<hr \/>\n<p><strong>Washington D.C., May 22, 2025<\/strong> \u2014The following statement may be attributed to the Asthma and Allergy Foundation of America\u2019s (AAFA) President and CEO Kenneth Mendez:<\/p>\n<p>\u201cWe appreciate the growing attention to the chronic disease burden faced by our community. There are an estimated 28 million people in the United States with asthma, of which 5 million are children. According to the Center for Disease Control and Prevention\u2019s (CDC) National Center for Health Statistics, about 1 in 3 adults and 1 in 4 children in the United States have a seasonal allergy, food allergy, or eczema.<\/p>\n<p>Take asthma, for example \u2013 this chronic disease requires proper understanding and care. Asthma is a chronic disease that causes inflammation and swelling of the airways. AAFA believes in getting the right diagnosis and treatment quickly. We recommend seeing a board-certified specialist trained in allergic or pulmonary disease. \u00a0When asthma is caught and treated early, it prevents costly hospital visits and stops lung damage that can become permanent or even life-threatening.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-25756\" src=\"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg\" alt=\"Text on a teal background that says: We appreciate the growing attention to the chronic disease burden faced by our community. There are an estimated 28 million people in the United States with asthma, of which 5 million are children. According to the Center for Disease Control and Prevention\u2019s (CDC) National Center for Health Statistics, about 1 in 3 adults and 1 in 4 children in the United States have a seasonal allergy, food allergy, or eczema. \" width=\"450\" height=\"563\" \/><\/p>\n<p>Assessment and early diagnosis of allergic disease can prevent unnecessary emergencies, work and school absenteeism, and morbidity. Achieving better health outcomes requires strong support for programs that focus on environmental interventions, patient education, and chronic disease surveillance. This focus improves health outcomes, lowers health care costs, and helps people remain active at work or school. That\u2019s why AAFA supports continued funding of the CDC\u2019s National Asthma Control Program, which reduced asthma mortality by 41%. AAFA also advocates for greater access to well-trained specialists who are best equipped to manage and treat asthma and allergies. Continued federal investment, through NIH and other mechanisms, is essential to advancing research into the developmental origins, causes, and treatments of asthma and other allergic diseases.\u201d<\/p>\n<p>For more information about the critical funding needs of the CDC&#8217;s National Asthma Control Program (NACP) and the National Institutes of Health (NIH): <a href=\"https:\/\/community.aafa.org\/blog\/urgent-action-needed-to-protect-our-community\" target=\"_blank\" rel=\"noopener\">https:\/\/community.aafa.org\/blog\/urgent-action-needed-to-protect-our-community<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=&#8221;Content Row&#8221; module_class=&#8221;blog-single&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Press Contact&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; link_font=&#8221;||||on|||#008c99|&#8221; link_text_color=&#8221;#008c99&#8243; header_2_font=&#8221;|600|||||||&#8221; header_2_text_color=&#8221;#008c99&#8243; header_2_font_size=&#8221;39px&#8221; header_3_font=&#8221;|600|||||||&#8221; header_3_text_align=&#8221;left&#8221; header_3_text_color=&#8221;#008c99&#8243; header_3_font_size=&#8221;28px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Press Contact:<\/strong><br \/>Andy Spears<br \/>Public Affairs Manager<br \/>Asthma and Allergy Foundation of America (AAFA)<br \/><a href=\"mailto:media@aafa.org\" target=\"_blank\" rel=\"noopener\"><span class=\"__eae_cssd\">media@aafa.org<\/span><\/a><\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;About &#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; link_font=&#8221;||||on|||#008c99|&#8221; link_text_color=&#8221;#008c99&#8243; link_line_height=&#8221;1.7em&#8221; ul_line_height=&#8221;1.7em&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_text_color=&#8221;#008c99&#8243; header_2_font_size=&#8221;39px&#8221; header_3_font=&#8221;|600|||||||&#8221; header_3_text_align=&#8221;left&#8221; header_3_text_color=&#8221;#008c99&#8243; header_3_font_size=&#8221;28px&#8221; background_color=&#8221;#F5EDDF&#8221; custom_padding=&#8221;4%|4%|4%|4%|true|true&#8221; box_shadow_style=&#8221;preset2&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>About AAFA<\/strong><\/p>\n<p>Founded in 1953, AAFA is the oldest and largest non-profit patient organization dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education, advocacy, and support. AAFA offers extensive support for individuals and families affected by asthma and allergic diseases, such as food allergies and atopic dermatitis (eczema). Through its online patient support communities, network of regional chapters, and collaborations with community-based groups, AAFA empowers patients and their families by providing practical, evidence-based information and community programs and services. AAFA is the only asthma and allergy patient advocacy group that is certified to meet the standards of excellence set by the National Health Council. For more information, visit:\u00a0<a href=\"https:\/\/aafa.org\/\">aafa.org<\/a> and <a href=\"https:\/\/kidswithfoodallergies.org\/\" target=\"_blank\" rel=\"noopener\">kidswithfoodallergies.org<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NewsSurveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases Washington D.C., May 22, 2025 \u2014The following statement may be [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":25756,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[32],"tags":[],"class_list":["post-25745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Chronic Disease Prevalence in the United States<\/title>\n<meta name=\"description\" content=\"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chronic Disease Prevalence in the United States\" \/>\n<meta property=\"og:description\" content=\"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"Asthma and Allergy Foundation of America\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-23T15:55:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-23T22:57:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tanya Bumgardner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Chronic Disease Prevalence in the United States\" \/>\n<meta name=\"twitter:description\" content=\"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tanya Bumgardner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/\"},\"author\":{\"name\":\"Tanya Bumgardner\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#\\\/schema\\\/person\\\/de55879e2f85645b23f9c2fb679a89ef\"},\"headline\":\"Chronic Disease Prevalence in the United States\",\"datePublished\":\"2025-05-23T15:55:54+00:00\",\"dateModified\":\"2025-05-23T22:57:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/\"},\"wordCount\":1056,\"image\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/kenny-statement-on-maha-SM.jpg\",\"articleSection\":[\"Press Release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/\",\"url\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/\",\"name\":\"Chronic Disease Prevalence in the United States\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/kenny-statement-on-maha-SM.jpg\",\"datePublished\":\"2025-05-23T15:55:54+00:00\",\"dateModified\":\"2025-05-23T22:57:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/#\\\/schema\\\/person\\\/de55879e2f85645b23f9c2fb679a89ef\"},\"description\":\"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#primaryimage\",\"url\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/kenny-statement-on-maha-SM.jpg\",\"contentUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/kenny-statement-on-maha-SM.jpg\",\"width\":1080,\"height\":1350,\"caption\":\"Text on a teal background that says: We appreciate the growing attention to the chronic disease burden faced by our community. There are an estimated 28 million people in the United States with asthma, of which 5 million are children. According to the Center for Disease Control and Prevention\u2019s (CDC) National Center for Health Statistics, about 1 in 3 adults and 1 in 4 children in the United States have a seasonal allergy, food allergy, or eczema.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/aafa.org\\\/chronic-disease-prevalence-in-the-united-states\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Press Release\",\"item\":\"https:\\\/\\\/aafa.org\\\/news\\\/press-releases\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chronic Disease Prevalence in the United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\",\"url\":\"https:\\\/\\\/aafa.org\\\/\",\"name\":\"Asthma and Allergy Foundation of America\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/aafa.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#\\\/schema\\\/person\\\/de55879e2f85645b23f9c2fb679a89ef\",\"name\":\"Tanya Bumgardner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3db672b6f6759437e30aaef65695350853409f2009b870e60d3429729ee67c41?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3db672b6f6759437e30aaef65695350853409f2009b870e60d3429729ee67c41?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3db672b6f6759437e30aaef65695350853409f2009b870e60d3429729ee67c41?s=96&d=mm&r=g\",\"caption\":\"Tanya Bumgardner\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Chronic Disease Prevalence in the United States","description":"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/","og_locale":"en_US","og_type":"article","og_title":"Chronic Disease Prevalence in the United States","og_description":"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases","og_url":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/","og_site_name":"Asthma and Allergy Foundation of America","article_published_time":"2025-05-23T15:55:54+00:00","article_modified_time":"2025-05-23T22:57:38+00:00","og_image":[{"width":1080,"height":1350,"url":"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg","type":"image\/jpeg"}],"author":"Tanya Bumgardner","twitter_card":"summary_large_image","twitter_title":"Chronic Disease Prevalence in the United States","twitter_description":"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases","twitter_misc":{"Written by":"Tanya Bumgardner","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#article","isPartOf":{"@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/"},"author":{"name":"Tanya Bumgardner","@id":"https:\/\/aafa.org\/#\/schema\/person\/de55879e2f85645b23f9c2fb679a89ef"},"headline":"Chronic Disease Prevalence in the United States","datePublished":"2025-05-23T15:55:54+00:00","dateModified":"2025-05-23T22:57:38+00:00","mainEntityOfPage":{"@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/"},"wordCount":1056,"image":{"@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg","articleSection":["Press Release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/","url":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/","name":"Chronic Disease Prevalence in the United States","isPartOf":{"@id":"https:\/\/aafa.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#primaryimage"},"image":{"@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg","datePublished":"2025-05-23T15:55:54+00:00","dateModified":"2025-05-23T22:57:38+00:00","author":{"@id":"https:\/\/aafa.org\/#\/schema\/person\/de55879e2f85645b23f9c2fb679a89ef"},"description":"Surveillance, patient education programs, and research funding are critical to improving health outcomes for people with asthma and allergic diseases","breadcrumb":{"@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#primaryimage","url":"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg","contentUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2025\/05\/kenny-statement-on-maha-SM.jpg","width":1080,"height":1350,"caption":"Text on a teal background that says: We appreciate the growing attention to the chronic disease burden faced by our community. There are an estimated 28 million people in the United States with asthma, of which 5 million are children. According to the Center for Disease Control and Prevention\u2019s (CDC) National Center for Health Statistics, about 1 in 3 adults and 1 in 4 children in the United States have a seasonal allergy, food allergy, or eczema."},{"@type":"BreadcrumbList","@id":"https:\/\/aafa.org\/chronic-disease-prevalence-in-the-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Press Release","item":"https:\/\/aafa.org\/news\/press-releases\/"},{"@type":"ListItem","position":2,"name":"Chronic Disease Prevalence in the United States"}]},{"@type":"WebSite","@id":"https:\/\/aafa.org\/#website","url":"https:\/\/aafa.org\/","name":"Asthma and Allergy Foundation of America","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aafa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/aafa.org\/#\/schema\/person\/de55879e2f85645b23f9c2fb679a89ef","name":"Tanya Bumgardner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3db672b6f6759437e30aaef65695350853409f2009b870e60d3429729ee67c41?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3db672b6f6759437e30aaef65695350853409f2009b870e60d3429729ee67c41?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3db672b6f6759437e30aaef65695350853409f2009b870e60d3429729ee67c41?s=96&d=mm&r=g","caption":"Tanya Bumgardner"}}]}},"_links":{"self":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts\/25745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/comments?post=25745"}],"version-history":[{"count":7,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts\/25745\/revisions"}],"predecessor-version":[{"id":25759,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts\/25745\/revisions\/25759"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/media\/25756"}],"wp:attachment":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/media?parent=25745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/categories?post=25745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/tags?post=25745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}